Jefferies Financial Group reissued a 'buy' rating on Monte Rosa Therapeutics, whose stock trades on the Nasdaq exchange.
1 report, 1 independent
Updated Aug 3
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Jefferies Financial Group reissued a 'buy' rating on Monte Rosa Therapeutics, whose stock trades on the Nasdaq exchange.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Monte Rosa Therapeutics
biotechnology company
Nothing else this week.
-
Jefferies Financial Group
American financial services company
-
Nasdaq
American fully electronic stock exchange
-
Nasdaq
American fully electronic stock exchange
- AppLovin stock is traded on Nasdaq, and both AppLovin and Trade Desk operate in the competitive digital advertising technology landscape.
- GOWell Energy Technology announced its commencement of trading on the Nasdaq stock exchange, led by CEO Guillaume Borrel, with operational bases in New York and Singapore.
Related events
- Jefferies Financial Group reissued a buy rating for Dassault Aviation, while MarketBeat aggregated the stock data.
- Jefferies Financial Group reissued a 'buy' rating on Mitchells & Butlers shares.
- Jefferies Financial Group reissued a 'hold' rating on The Renewables Infrastructure Group, a company listed on the London Stock Exchange.
- Jefferies Financial Group reaffirmed a buy rating on the stock, while MarketBeat provided the average rating, and William Blair started coverage for Presidio Production.
- Analysts provided price targets and ratings for Ross Stores, Inc., which was traded on the Nasdaq exchange.